IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial

The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and completely re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jensen, Alexandra (VerfasserIn) , Nikoghosyan, Anna (VerfasserIn) , Lossner, Karen (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Münter, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 2, 2012
In: BMC cancer
Year: 2012, Jahrgang: 12
ISSN:1471-2407
DOI:10.1186/1471-2407-12-163
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-163
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-163
Volltext
Verfasserangaben:Alexandra D. Jensen, Anna V. Nikoghosyan, Karen Lossner, Klaus K. Herfarth, Jürgen Debus and Marc W. Münter
Beschreibung
Zusammenfassung:The COSMIC trial is designed to evaluate toxicity in dose-escalated treatment with intensity-modulated radiotherapy (IMRT) and carbon ion boost for malignant salivary gland tumors (MSGT) of the head and neck including patients with inoperable/ incompletely resected MSGTs (R2-group) and completely resected tumors plus involved margins or perineural spread (R1-group).
Beschreibung:Gesehen am 22.08.2018
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-163